Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Hemasphere|November 29, 2023
CK2β Regulates Hematopoietic Stem Cell Biology and ErythropoiesisLaura Quotti Tubi, Sara Canovas Nunes, Elisa Mandato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic featuresMarco Pizzi, Luisa Lorenzi, Andrea De Crescenzo, et al.
Frontiers in Immunology|January 30, 2023
CK2β-regulated signaling controls B cell differentiation and functionLaura Quotti Tubi, Elisa Mandato, Sara Canovas Nunes, et al.
British Journal of Haematology|March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre studyNicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Cancers|December 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo, et al.
Frontiers in Oncology|July 10, 2023
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignanciesFrancesco Angotzi, Marco Petrella, Tamara Berno, et al.
The Oncologist|December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell LymphomasMichele Merli, Marco Frigeni, Laurent Alric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell LymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.
The Lancet. Haematology|September 20, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 studyCarlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, et al.
Pageof 18